Amazon (AMZN) Form 144 Filing Reports 19,119-Share Sale on NASDAQ
Rhea-AI Filing Summary
Form 144 filed for AMZN reports a proposed sale of 19,119 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $4,197,958.83, to be sold on 10/01/2025 on NASDAQ. The shares were acquired as restricted stock units on 09/28/2020. The filing lists recent executed sales by the same seller under a Rule 10b5-1 plan: 2,500 shares on 09/02/2025 ($558,725.00), 6,835 on 08/21/2025 ($1,514,782.95), 4,784 on 08/15/2025 ($1,111,409.79), and 2,500 on 08/01/2025 ($542,500.00). The filer represents compliance with Rule 10b5-1 procedures and attests there is no undisclosed material adverse information.
Positive
- Clear disclosure of the proposed sale amount (19,119 shares) and aggregate market value ($4,197,958.83).
- Use of Rule 10b5-1 trading plan is documented and recent executed plan sales are itemized with dates and gross proceeds.
- Attestation states the seller does not possess undisclosed material adverse information, indicating compliance with disclosure requirements.
Negative
- Insider sale activity is reported, which may be viewed negatively by some investors despite compliance documentation.
- Filing lacks issuer context about any related corporate developments; the document only covers the sale notice itself.
Insights
TL;DR Insider intends to sell vested RSUs under a 10b5-1 plan; recent sales are documented and the filer attests to no undisclosed material information.
The filing documents a routine Section 144 notice for 19,119 shares acquired as restricted stock units on 09/28/2020, with sale execution through Morgan Stanley Smith Barney on NASDAQ. Multiple recent 10b5-1 plan sales in August–September 2025 are disclosed with corresponding gross proceeds. This is a compliance-driven disclosure showing planned liquidity from previously granted equity rather than an operational update from the issuer.
TL;DR The disclosure follows required procedures and cites a 10b5-1 plan; signature attestation of no undisclosed material info is included.
The filer explicitly indicates reliance on Rule 10b5-1 trading instructions and provides the plan adoption/sale dates and amounts. The form includes the required attestation about absence of material nonpublic information at the time of plan adoption or instruction. From a governance perspective, the document meets procedural disclosure expectations for insider sales.